Moderna/NIAID send “mRNA coronavirus vaccine canditates” to Dr Ralph Baric

On December 12, 2019, Dr Ralph Baric of University of North Carolina at Chapel Hill, signed an agreement (pg 105) to receive the “mRNA coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna”. [1, 2, 3, 4]  Thus NIH has joint ownership of Moderna's mRNA coronavirus vaccine. Dr Baric has a long history of coronavirus chimeric research and collaboration with the Wuhan Virology Lab plus knows how to profit from a pandemic.

Study concludes engineered viruses may be too risky to pursue

Chinese virologist Shi Zheng-Li in Wuhan, together with US virologist Ralph Baric, published a paper that “synthetically re-derived an infectious…virus”, concluding that building chimeric viruses maybe too risky to pursue. They took a 2002 SARS virus and inserted the protein from a rufous horseshoe bat, creating a new infectious human pathogen.  It was intended to “warn the world” of a potential risk of SARS-CoV re-emergence! The study was funded by NIH via EcoHealth Alliance, and NGO who's president is Peter Daszak.  This study was approved by NIH to continue even though it came under the Gain of Function funding moratorium. In 2020, Daszak thanked Dr Fauci via email, for dismissing theories that SARS-CoV-2 could be man-made. In February 2021, Daszak represented the US on the WHO probe in to the origins of SARS-CoV-2.

ACE2 Receptor identified as bat coronavirus infection site for humans.

In an October 30, 2013 paper in Nature, Shi Zheng-Li and Peter Daszak et al reported a key discovery: that certain bat viruses could potentially infect humans without first jumping to an intermediate animal. By isolating a live SARS-like bat coronavirus (from a rufous horseshoe bat in Yunnan mine 2012) for the first time, bat SL-CoV-WIV1, Shi's team found that it could enter human cells through a protein called the ACE2 receptor. [1]